% Expired Patents = 83.3

CIPO Patents = 2

EPO Patents = 2

Forward Citations = 8

Loading Chart...

9 inventors (with patents filed for the assignee):

Gary Paul Cook (3 out of 12 patents)

Mike Jaffe (3 out of 3 patents)

Perry Calias (3 out of 7 patents)

4. Michael Manzo (3 out of 3 patents)

5. Michael A Patane (3 out of 52 patents)

6. Pierre Roy (2 out of 53 patents)

7. Peyman Moslemy (2 out of 2 patents)

8. William Schubert (2 out of 2 patents)

9. William Isom (2 out of 2 patents)

10. Gary Cook (7 patents)

11. Mike Patane (0 patent)

12. Mike Patane (0 patent)

13. Roy Pierre (0 patent)

6 patents: Sort by Forward Citations

1. 10376463 - Ocular iontophoretic delivery of dexamethasone and formulations thereof (2019-08-13),

2. 9937074 - Iontophoretic contact lens (2018-04-10),

3. 9820935 - Delivery of corticosteroids through iontophoresis (2017-11-21),

4. 9539141 - System and method for ocular iontophoresis with buffering (2017-01-10),

5. 9180292 - System and method for ocular iontophoresis with buffering (2015-11-10),

6. 9149525 - Delivery of corticosteroids through iontophoresis (2015-10-06),

Company Overview

Eyegate Pharmaceuticals, Inc. is a clinical-stage specialty pharmaceutical company focused on developing and commercializing innovative ophthalmic products. The company's lead product candidate, EGP-437, is in late-stage development for the treatment of non-infectious anterior uveitis, a rare inflammatory eye condition. Eyegate Pharmaceuticals is committed to addressing unmet medical needs in the field of ophthalmology through the development of novel therapies and drug delivery technologies.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

6 Patents

#168 in Waltham, MA

#2,545 in Massachusetts

#44,981 in US

Waltham, MA, United States of America

Eyegate Pharmaceuticals, Inc.

Forward Citations = 8

9 inventors:

Gary Paul Cook (3 out of 12 patents)

Mike Jaffe (3 out of 3 patents)

Perry Calias (3 out of 7 patents)

4. Michael Manzo (3 out of 3 patents)

5. Michael A Patane (3 out of 52 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Eyegate Pharmaceuticals, Inc.. Retrieved from https://idiyas.com/company/eyegate-pharmaceuticals

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

2 patents (CIPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

2 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]